In addition, in the coming years, oral GLP-1 receptor agonists and injectable formulations that require less-frequent ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep ...

Daewoong Pharmaceutical announced Tuesday that it has filed for a domestic patent for a new obesity drug that suppresses ...

It is also expected to be cheaper, since it's easier to produce (orforglipron isn't a peptide like other GLP-1 drugs). However, the clock is ticking. Novo Nordisk already has an oral semaglutide ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Depending on the medication, the effects can last for a minimum of 24 hours to a few weeks. Examples include dulaglutide, ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...